.Operating system Therapies will definitely specify on the NYSE American stock substitution this mor...
.ALX Oncology's phase 2 stomach cancer response price has actually compromised. After seeing its CD4...
.Another of Ionis Pharmaceuticals' key midphase readouts has disappointed assumptions, cuing the bio...
.While Biogen's pharma peers are actually searching for late-stage resources along with little risk,...
.Instil Biography has been a biotech looking for a pipe after it junked its lead possessions over th...
.Biogen has actually handed back civil rights to a very early Alzheimer's condition course to Denali...
.Welcome to this week's Chutes & Ladders, our summary of considerable management hirings, shootin...
.Tip's effort to handle an uncommon hereditary health condition has actually reached yet another tro...
.Vir Biotechnology's second-quarter incomes record wasn't short of significant information. The prov...
.Galapagos has stopped briefly enrollment in a trial of a BCMA-directed CAR-T cell therapy, pumping ...